ALDH1A1 and lip and oral cavity carcinoma: Table 1 shows that strong immunohistochemical expression for ALDH1 was observed in 16 of the 63 tumors (25.4%) with significant difference among the subtypes of oral cancer (p = 0.021), and the majority were BSCCs (56.3%).